Panama
EXUMA Biotech is a clinical-stage biotech company focused on advancing gene vector delivery to enhance patient access to innovative cell and gene therapies. The company recently announced Phase 1 results for its Autologous HER2 Directed, Tumor Metabolism Regulated (TMR) CAR-T product at ASCO GI 2025. EXUMA Biotech also presented early clinical and translational findings from solid tumor cell therapy and in vivo CAR engineering research at the AACR Annual Meeting 2023. Dr. Sid Kerkar discussed how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineering. The company was founded in 2015 and has been actively researching and developing cell and gene therapies for over a decade.
Browsing, company names, locations and sectors are always free. A free account adds 5 contact releases every month — e-mail and phone, view or export. Need more? Contact packs start at 19 € for 50, or upgrade to a monthly plan.
Yes — no card required. Browsing is always free, and a free account adds 5 contact releases every month.
Your first 5 contact releases each month are included in the free account. After that, packs start at 19 € for 50 contacts (view or export), or a monthly plan for regular use.
Companies are harvested from the open web — registers, websites and industry directories — not self-registered sign-ups. Contact details are shown only once you use a release or credit, never invented.